irec: international center for recurrent head and neck cancer
Published 2 years ago • 161 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
2:36
ca209-9ky: imrt nivolumab for recurrent head and neck squamous cell cancer
-
2:41
advances in head and neck cancer
-
1:13
keynote-b84: pepinemab pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
-
2:01
head and neck cancer in the uk
-
1:22
the extreme regimen for head and neck cancer
-
1:59
potential of immunotherapy in head and neck cancer
-
2:08
future directions for head and neck cancer
-
1:52
esmo 2022 highlights in head and neck cancer
-
2:54
extreme regimen vs. cetuximab cisplatin paclitaxel for recurrent/metastatic head and neck cancer
-
2:42
recent advances in targeted therapy for head and neck cancer
-
2:12
unanswered questions in head and neck cancer
-
1:03
advances in targeted therapy for head & neck and thyroid cancers
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
3:04
head and neck cancer at asco 2022
-
2:55
tacti-002 and tacti-003: eftilagimod alpha for metastatic head and neck squamous cell carcinoma
-
1:47
narrower side margin excision for head and neck bcc in the japanese population
-
0:39
predicting responses to immunotherapy in head and neck cancer
-
1:11
dr. vokes on the treatment landscape of recurrent head and neck cancer
-
2:28
palbociclib for platinum-resistant metastatic head and neck cancer